NICE considers QOF indicator on alcohol consumption

The QOF may include an indicator on alcohol consumption from 2013/14, after NICE decided to undertake further development work in this area.

At its meeting on Thursday, NICE's QOF review committee decided that there was merit in alcohol consumption indicator. But it thought that more evidence was needed on who should be included in the target group for any indicator.

The committee has decided that, from 2012/13 QOF should include an indicator on statin use in patients who have hypertension and are at risk of cardiovascular disease.

It also recommended that an indicator be introducing in 2012/13 for a General Practice Physical Activity Questionnaire assessment for patients who have hypertension and are at risk of cardiovascular disease.

Pilots of these indicators on statin use and physical activity will begin in October.

Once the findings of the pilots have been reported, the NICE QOF committee will present recommendations on indicators for inclusion in the 2012/13 QOF. The GPC and NHS Employers will then negotiate on which of these will be included.

Related news: NICE backs minimum alcohol price to beat binge drinkers

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

BROWSE BY THERAPEUTIC AREA

A-Z listing of therapeutic areas. Find the latest clinical news and education

SEE ALL TOPICS AND PAGES

Browse a list of all of the pages and topics on GPonline

Pain Resource Centre

Information on chronic and neuropathic pain

Otitis Externa Toolkit

Resources to help treat this outer ear infection

GPs practising in the UK can request to receive free copies of GP by completing our online registration form. For paid subscriptions to GP visit our subscriptions site.